Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Medical sciences. 2022;10(2). https://doi.org/10.3390/MEDSCI10020032, PubMed PMID: 35736352.
Aortic Stenosis - PubMed [Internet]. [cited 2025 Aug 11]. Available from: https://pubmed.ncbi.nlm.nih.gov/32491560/
Pilgrim T, Englberger L, Rothenbühler M, Stortecky S, Ceylan O, O’Sullivan CJ, et al. Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modality. Heart. 2015;101(1):30–6. 10.1136. /HEARTJNL-2014-306106, PubMed PMID: 25163691.
Mahmaljy H, Tawney A, Young M. Transcatheter Aortic Valve Replacement. StatPearls. 2023 Jul 24. PubMed PMID: 28613729.
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):E876–94. 10. 1161/CIR.0000000000001062 PubMed PMID: 35363500.
Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, et al. Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and design. J Card Fail. 1999;5(3):276–82. https://doi.org/10.1016/S1071-9164. (99)90013-1 PubMed PMID: 10496201.
Article CAS PubMed Google Scholar
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154(2):260–6. https://doi.org/10.1016/j.ahj.2007. 01.041 PubMed PMID: 17643574.
Jalava MP, Laakso T, Virtanen M, Niemelä M, Ahvenvaara T, Tauriainen T, et al. Transcatheter and Surgical Aortic Valve Replacement in Patients With Recent Acute Heart Failure. Ann Thorac Surg. 2020;109(1):110–7. https://doi.org/10.1016/j.athoracsur.2019.05.044. PubMed PMID: 31288017.
Kaewkes D, Ochiai T, Flint N, Patel V, Patel J, Kim I, et al. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis Hospitalized With Acute Heart Failure. Am J Cardiol. 2021;144:100–10. https://doi.org/10.1016/j.amjcard.2020.12.046. PubMed PMID: 33383005.
Thilen M, James S, Ståhle E, Lindhagen L, Christersson C. Pre-operative heart failure worsens outcome after aortic valve replacement irrespective of left ventricular ejection fraction. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):127–34. https://doi.org/10.1093/EHJQCCO/QCAB008. PubMed PMID: 33543245.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. 10.1136. /BMJ.N71 PubMed PMID: 33782057.
Ottawa Hospital Research Institute [Internet]. [cited 2025 Aug 16]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557–60. https://doi.org/10.1136/BMJ.327.7414.557, PubMed PMID: 12958120.
Chen S, Redfors B, Crowley A, Ben-Yehuda O, Summers M, Hahn RT, et al. Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries. Eur J Heart Fail. 2020;22(10):1866–74. 10. 1002/EJHF.1841, PubMed PMID: 32441856.
Fukutomi M, Onishi T, Ando T, Higuchi R, Hagiya K, Saji M, et al. Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new-generation devices: Insights from the LAPLACE-TAVI registry. Catheter Cardiovasc Interv. 2024;104(7):1469–76. 10. 1002/CCD.31261, PubMed PMID: 39402889.
Popovic B, Molho A, Varlot J, Fay R, Metzdorf PA, Elfarra M, et al. Prognostic influence of acute decompensated heart failure in patients planned for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2020;96(5):E542–51. 10. 1002/CCD.28813, PubMed PMID: 32100937.
Strange JE, Nouhravesh N, Schou M, Christensen DM, Holt A, Østergaard L, et al. High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes. Am Heart J. 2024;268:53–60. PubMed PMID: 37972676.
Article CAS PubMed Google Scholar
Stein EJ, Fearon WF, Elmariah S, Kim JB, Kapadia S, Kumbhani DJ, et al. Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis. J Am Heart Assoc. 2022;11(7):23466. https://doi.org/10.1161/JAHA.121.023466/SUPPL_FILE/JAH37260-SUP-0001-SUPINFO.PDF.
Gradman AH, Alfayoumi F. From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease. Prog Cardiovasc Dis. 2006;48(5):326–41. https://doi.org/10.1016/j.pcad.2006.02.001.
Bing R, Cavalcante JL, Everett RJ, Clavel MA, Newby DE, Dweck MR. Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis. JACC Cardiovasc Imaging. 2019;12(2):283. https://doi.org/10.1016/j.jcmg.2018.11.026. PubMed PMID: 30732723.
Article PubMed PubMed Central Google Scholar
Chin CWL, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, et al. Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis. JACC Cardiovasc Imaging. 2017;10(11):1320–33. https://doi.org/10.1016/j.jcmg.2016.10.007. PubMed PMID: 28017384.
Elias A, Agbarieh R, Saliba W, Khoury J, Bahouth F, Nashashibi J, et al. SOFA score and short-term mortality in acute decompensated heart failure. Sci Rep. 2020;10(1). https://doi.org/10.1038/S41598-020-77967-2.
Younes AM, Mahmoud AK, Kamel I, Albeyoumi H, Maraey A, Khalil M. Outcomes of transcatheter aortic valve replacement in heart failure patients: Insights from the National Readmission Database. Cardiovasc Revascularization Med. 2025 Mar. https://doi.org/10.1016/J.CARREV.2025.03.002.
Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail. 2018;6(4):273–85. https://doi.org/10.1016/J.JCHF.2017.09.023.
Kitakata H, Kohno T, Kohsaka S, Shiraishi Y, Parizo JT, Niimi N, et al. Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry. J Am Heart Association J Am Heart Assoc. 2020;9:14949. https://doi.org/10.1161/JAHA.119.014949.
Su K, Kato T, Toyofuku M, Morimoto T, Yaku H, Inuzuka Y, et al. Association of Previous Hospitalization for Heart Failure With Increased Mortality in Patients Hospitalized for Acute Decompensated Heart Failure. Circ Rep. 2019;1(11):CR–19. https://doi.org/10.1253/CIRCREP.CR-19-0054.
Adelborg K, Szépligeti S, Sundbøll J, Horváth-Puhó E, Henderson VW, Ording A, et al. Risk of Stroke in Patients with Heart Failure: A Population-Based 30-Year Cohort Study. Stroke. 2017;48(5):1161–8. https://doi.org/10.1161/STROKEAHA.116.016022/SUPPL_FILE/STR_STROKE-2016-016022_SUPP1.PDF.
Burke DJ, Baig T, Goyal P, Kamel H, Sharma R, Parikh NS, et al. Duration of Heightened Risk of Acute Ischemic Stroke After Hospitalization for Acute Systolic Heart Failure. J Am Heart Assoc. 2023;12(6):27179. https://doi.org/10.1161/JAHA.122.027179/SUPPL_FILE/JAH38247-SUP-0001-TABLES1.PDF.
Doehner W, Böhm M, Boriani G, Christersson C, Coats AJS, Haeusler KG, et al. Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis. Eur J Heart Fail. 2023;25(12):2107–29. https://doi.org/10.1002/EJHF.3071.
Vora AN, Dai D, Matsuoka R, Harrison JK, Hughes GC, Sherwood MW, et al. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2018;11(17):1746–56. https://doi.org/10.1016/j.jcin.2018.05.042.
Mentias A, Saad M, Girotra S, Desai M, Elbadawi A, Briasoulis A, et al. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019;12(21):2119–29. https://doi.org/10.1016/j.jcin.2019.06.019.
Article PubMed PubMed Central Google Scholar
Albabtain MA, Arafat AA, Alonazi Z, Aluhaydan H, Alkharji M, Alsaleh R, et al. Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens. Braz J Cardiovasc Surg. 2022;37(6):836. https://doi.org/10.21470/1678-9741-2020-0538.
Article PubMed PubMed Central Google Scholar
Khan H, Gilani A, Qayum I, Khattak T, Haq F, Anwar MZ, et al. An Analysis of the Predictors of Major Bleeding After Transcatheter Aortic Valve Transplantation Using the National Inpatient Sample (2015–2018). Cureus. 2021;13(6):e16022–16022. https://doi.org/10.7759/CUREUS.16022.
Article PubMed PubMed Central Google Scholar
Li SX, Patel NK, Flannery LD, Cigarroa RJ, Shaqdan AW, Erickson P, et al. Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2021;97(1):E172–8. https://doi.org/10.1002/CCD.28989.
Sardar MR, Goldsweig AM, Abbott JD, Sharaf BL, Gordon PC, Ehsan A, et al. Vascular complications associated with transcatheter aortic valve replacement. Vascular Med (United Kingdom). 2017;22(3):234–44. https://doi.org/10.1177/1358863X17697832/SUPPL_FILE/VMJ697832_SUPPLEMENTARY_TABLES.PDF.
Czerwińska-Jelonkiewicz K, Michałowska I, Witkowski A, Dąbrowski M, Księżycka-Majczyńska E, Chmielak Z, et al. Vascular complications after transcatheter aortic valve implantation (TAVI): Risk and long-term results. J Thromb Thrombolysis. 2014;37(4):490–8. https://doi.org/10.1007/S11239-013-0996-7.
Comments (0)